BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Drug Discovery

Aridis Pharmaceuticals COVID mAb AR-712 Neutralizes SARS-CoV-2 Delta Variant

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threaten...

July 13, 2021 | News

Biological E to purchase CpG 1018 adjuvant from Dynavax

DYNAVAX AND BIOLOGICAL E ANNOUNCE COMMERCIAL SUPPLY AGREEMENT OF DYNAVAX’S CpG 1018 ADJUVANT FOR BIOLOGICAL E’S COVID-19 VACCINE CANDIDATE Dyn...

July 06, 2021 | News

Roche to drive therapies to treat breast and lung cancer

According to Globocan, in 2020 the global burden of cancer increased to 19.3 million new cases and 10 million deaths[1]. Worldwide, the most common type of...

July 06, 2021 | News

SINOMED announces a clinical collaboration with the National University of Ireland Galway

The PIONEER IV trial is a prospective, random trial that will take place in 30 hospitals across Europe, enrolling 2,540 patients and involve patient...

July 05, 2021 | News

Arctic Vision to develop innovative therapies for pan-ocular diseases

Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pan-ocular diseases, announcing today...

July 05, 2021 | News

10x Genomics to Leverage Robust Single-Cell Technologies for Drug Development

To Support Global BioPharma Companies Leveraging Robust Single-Cell Technologies for Accelerated and Improved Drug Development Genuity Science, a ge...

June 28, 2021 | News

SP launches SP Hull LyoStar(R) 4.0 to enhance speed to market in drug development

New advanced pilot-scale lyophilizer supports rapid and highly effective freezedry cycle development, optimization and process scale-up Based on a...

June 23, 2021 | News

Eurofins Discovery Expand their Antibody Discovery Platform

Eurofins Discovery's global clients will have access to ImmunoPrecise's end-to-end antibody discovery capabilities using wild type and best-in-class i...

June 23, 2021 | News

Australia's Viraleze™ is highly effective against Alpha, Beta and Gamma COVID variants

The results from the renowned Scripps Research Institute in the US confirm that SPL7013, the active ingredient in Viraleze™, is highly acti...

June 18, 2021 | News

Gilead Sciences committed to Global Elimination of Hepatitis C

Data Presented at the Global Hepatitis Summit Show that Virally Suppressed Patients from Taiwan with Renal or Hepatic Impairment had High Rates of Vi...

June 18, 2021 | News

Debiopharm and Ubix Therapeutics o Develop a New Anti-Cancer Modality -

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech co...

June 17, 2021 | News

With Serum Institute as a partner, Novavax is poised to launch in India.

The Novavax trials conducted on 29,960 people in the US and Mexico have delivered results that equal the Pfizer NSE -1.09 % and Moderna jabs and do better ...

June 16, 2021 | News

Harbour BioMed and Dana-Farber to Advance Novel Biotherapies for Cancer Treatment

Harbour BioMed scientists and Dana-Farber researchers will be working together to develop novel oncologic drugs, including bispecific antibodies and CAR-T ...

June 16, 2021 | News

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

June 15, 2021 | News

Stay Connected